Health Tech Capitol | Cellular Logistics, Cellular Dynamics scientists to study heart treatment in pigs
16811
post-template-default,single,single-post,postid-16811,single-format-standard,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Cellular Logistics, Cellular Dynamics scientists to study heart treatment in pigs

06 Oct Cellular Logistics, Cellular Dynamics scientists to study heart treatment in pigs

Posted at 10:24h in Uncategorized by
0 Likes

UW-Madison researchers involved in two Madison-based stem cell companies have received a federal grant to test experimental therapies for heart failure in pigs.

The $765,000 grant, announced last week, will allow Dr. Amish Raval, co-founder of Cellular Logistics, and Dr. Tim Kamp, a founder of and consultant to Fujifilm Cellular Dynamics Inc., or FCDI, to test two related treatments on four groups of pigs after heart attacks.

More than 5 million Americans suffer from heart failure each year, according to the Centers for Disease Control and Prevention, typically after heart attacks damage heart muscle cells and impair the heart’s ability to pump blood.

Read more at the Wisconsin State Journal

No Comments

Sorry, the comment form is closed at this time.